Atrial Fibrillation Surgery Market Size, Share, Growth Report 2030

Atrial Fibrillation Surgery Market Size And Industry Analysis

The global atrial fibrillation surgery market accounted for USD 1,522.7 Million in 2020 and is expected to reach USD 4,240.0 Million by 2028, growing at a CAGR of 13.9% from 2021 to 2028.

Atrial fibrillation surgery is a medical operative procedure to treat atrial fibrillation or cardiac arrhythmia. It is a condition in which heart beats irregularly. This irregular heart beat is due to irregularities in the electric impulse send by the damaged heart tissues. The patient suffering from atrial fibrillation can experience stroke, heart failure, blood clots and other heart related complication leading to risk of death. The atrial fibrillation surgery is done to remove the damaged tissue by inserting catheter in the upper chamber of the heart which emits radio waves and regulates the electric impulse leading to regulated heart beats.

The increasing adoption of atrial fibrillation surgery for treating cardiac arrhythmia and atrial fibrillation are propelling the growth of the market.

Request Free Sample

COVID-19 Impact Analysis

The Covid-19 pandemic had tested the healthcare potential of all the countries across the globe. In the initial stage of Covid-19 outbreak the healthcare industry had prioritized treated of covid-19 patients. This resulted in postponement of non-emergency cardiac surgeries. This impacted the atrial fibrillation surgery market for short period. The Covid-19 outbreak had led to increase in investments for the development of healthcare industry and leading economies are more focusing on healthcare infrastructure development. This is development is estimated to have positive impact on atrial fibrillation market. The reduction in physical movements owing to stringent covid-19 lockdown and work from home working method had led to rise in obesity. The rising healthcare infrastructure developments and rise in number of patients suffering from atrial fibrillation owing to increased obesity is estimated to have positive impact on the atrial fibrillation surgery market.

Growth Factors

The major factor driving the growth of the market is upsurge in number of patients suffering from atrial fibrillation. In addition to this, rise in geriatric population, prevalence of diseases like obesity, hypertension, high cholesterol levels, and unhealthy lifestyles are contributing to the demand for atrial fibrillation surgery. The changes in life style including increased alcohol consumption and smoking are leading to prevalence of atrial fibrillation across the globe.

The rising adoption of atrial fibrillation treatments owing to reduced mortality rate and positive results of atrial fibrillation surgeries are fueling the market growth. Further, rising advancements in healthcare industry and rising awareness for the benefits of atrial fibrillation surgeries are contributing to the market growth. Additionally, the factors leading to rise in market growth are developing healthcare infrastructure in developing countries and development of non-invasive surgical techniques. The increasing incidents are of cardiac arrest and heart failure are estimated to drive the market in the forecast period.

Report Scope :

Procedure Segment Analysis Preview

Catheter ablation segment held a share of around 38.02% in 2020. This is attributable to better quality results provided by the catheter ablation procedures. In addition to this, the increasing adoption of minimum and non-invasive methods of operations are leading to the upsurge in demand for the catheter ablation procedures among the patients. The improved healthcare infrastructure development and rising demand for the non-pharmaceutical treatment methods are propelling the growth of the catheter ablation procedure segment. 

The rising patient awareness for the catheter ablation procedure owing to improved quality of life, reduction in symptoms of atrial fibrillation and cardiac arrhythmia. The catheter ablation procedures reduce the risk of death due to advancements in the atrial fibrillation symptoms. To eliminate the risk of blood clots, cardiac arrest and heart failure the catheter ablation procedure is getting popular as a treatment procedure.

Request Free Sample

End User Segment Analysis Preview

Ambulatory Surgical Centers segment will grow at a CAGR of over 14.8% from 2021 to 2028. This is attributable to rising advancements in healthcare infrastructure. Apart from the major factor contributing to the segment growth is availability of skilled labors involving expert surgeons and hospitality staff are contributing to the ambulatory surgical centers segment growth. The affordability of treatment procedures at ambulatory surgical centers are also majorly contributing to the growth. The rise in patients pool suffering from cardiac arrhythmia and atrial fibrillation are fueling the market demand.

Additionally, the segment is powered by growing geriatric population suffering from atherosclerosis, cardiac arrest and heart failure. The rapidly growing population with increased demand for treatments for atrial fibrillation are propelling the segment growth. The health issues like obesity, hypertension and rising cholesterol levels are leading increase in number of heart related dysfunctioning. The Covid-19 pandemic have resulted in upsurge in obesity among the people. This upsurge is estimated to fuel the growth of ambulatory surgical centers in the forecast period.

Regional Analysis Preview

The North America region held a share of 37.47% in 2020. This is attributable to the rise in patient pool suffering from atrial fibrillation and cardiac arrhythmia. U.S. among the other countries is majorly contributing to the growing patient pool. According to Centre for Disease Diagnosis and Prevention, U.S. is estimated to have 12.1 patients of atrial fibrillation till 2030. The presence of key market players associated with atrial fibrillation is contributing to the dominance of the North America region across the globe.

The manufactures and medical research institutes are focusing on the product innovation and development of new and advance devices for atrial fibrillation treatment. The new treatment techniques are also being practiced in the region owing to the increased demand for reduced pain, improved results, reduced risks. The non-invasive surgeries are increasing in demand in the North America region. The availability of favorable health insurance and policies are estimated to drive the growth of the segment

The Asia Pacific region is projected to grow at a CAGR of 15.8% over the forecast period. This surge is due to the huge population base and increase in number of atrial fibrillation patients The other factors contributing to the growth of the region are growing advancements in healthcare infrastructure owing to increasing investments by leading economies like Japan, China and India in healthcare industry.

The rising old-age population in the region are fueling the market growth in the region. The upsurge in per capita income have driven the atrial fibrillation market in the APAC region. The countries like Japan and China are holding the largest market share among other countries in the region owing to growing healthcare expenditure. The rising demand for atrial fibrillation surgery is estimated to propel the market growth in the forecast period.

Request Free Sample

Key Market Players & Competitive Landscape

Some of key players in atrial fibrillation surgery market are Biosense Webster, Inc., Siemens Healthcare, Boston Scientific Corporation, Abbott Laboratories, AtriCure Inc., Biotronik SE & Co., Ncontact Inc., Cardiofocus Inc, Medtronic plc and AtriAN Medical among others.

The atrial fibrillation market is witnessing entry of new market players like AtriAN Medical, Rhythm AI, Ablacon, Donisi Health and Cortify into the market. The new market players are exploring the market potential. While, the existing market players are focusing on the partnerships, mergers and acquisitions and collaborations to widen their existing product portfolio and strengthen their global and regional footprint. The major market players are also focusing on product innovation and integration of new technology into the portfolio to strengthen their market position.

For Instance, In September 2021, Abbott laboratories have acquired Walk Vascular to incorporate thrombectomy systems into Abbott’s existing endovascular product portfolio.

The global market is segmented as follows:

By Product

• Catheter Ablation
• Surgical Ablation

By Procedures

• Catheter Ablation
• Maze Surgery
• Surgical Ablation

By End User

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratories.

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa